CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


19-June-2012
Cerilliant introduces its latest cardiac drug Certified Spiking Solution® - (±)-Flecainide.

(±)-Flecainide, 1.0 mg/mL F-017
1.0 mg/mL in Methanol

Flecainide, marketed under trade names such as Almarytm, Apocard, Ecrinal, and Flécaine, is a class Ic antiarrhythmic drug used to prevent and treat a variety of cardiac arrhythmias. This Certified Spiking Solution® is suitable for use as a starting material in the preparation of calibrators, controls, or linearity standards in flecainide therapeutic drug monitoring methods by LC/MS or LC that ensure patients remain within the drug’s narrow therapeutic range.

Cerilliant also offers Certified Spiking Solutions® of other cardiac drugs with narrow therapeutic indexes such as digoxin, disopyramide, digitoxin, and clonidine.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn